Fibromuscular dysplasia (FMD) is a rare vascular disorder characterized by abnormal proliferation of smooth muscle cells and fibrous tissue in the walls of arteries. This ultimately leads to narrowing of the lumen of the vessels, changes in their morphology, and circulatory disorders. FMD can affect any vessel, but the renal arteries and arteries of the neck are most often affected. The main problem that patients face is the development of hypertension, as well as possible complications such as stroke or heart attack. The disease is more common in young women, but it can also develop in men and children.
History of the disease and interesting historical facts
Fibromuscular dysplasia was first described in the medical literature in 1938. Researchers noticed that this condition combined characteristics of both vasculitis and chronic diseases. Interestingly, FMD remained understudied for a long time due to its rarity and variability of clinical presentation, which led to an underestimation of its frequency of diagnosis. Over time, with the increasing use of X-ray and other imaging technologies such as CT and MRI, it became possible to diagnose this disease more accurately.
Epidemiology
The prevalence of FMD varies depending on the diagnostic methods and populations used. According to some estimates, FMD may occur in 3-4% of all cases of arterial hypertension in women aged 15 to 50 years. However, reliable statistical data on the prevalence of the disease require further research, since most cases remain undiagnosed. Notably, FMD is predominantly observed in women, which indicates a possible connection with hormonal factors or genetic predispositions.
Genetic predisposition to this disease
To date, no single gene has been identified that is responsible for the development of FMD, but it is assumed that the disease may be associated with mutations in certain genes, such as ACTA2. These mutations affect smooth muscle cells, disrupting their normal functioning and leading to pathological changes in the structure of blood vessels. In some cases, FMD is inherited in an autosomal dominant manner, which suggests a possible hereditary predisposition. However, further genetic studies are needed to more accurately understand the mechanisms of the diseases.
Risk factors for the development of this disease
There are various risk factors that may contribute to the development of FMD. These include:
- Environmental factors: exposure to chemical pollutants such as heavy metals.
- Connective tissue diseases: Autoimmune diseases may increase the risk.
- Hormonal changes: Factors related to the menstrual cycle influence the development of the condition.
- Age: Women between the ages of 15 and 50 are most susceptible to the disease.
These factors in combination can increase the incidence of the disease, so their consideration during screening and diagnosis is extremely important.
Diagnosis of this disease
Diagnosis of FMD begins with a clinical assessment and identification of the main symptoms, including:
- High blood pressure, often difficult to treat.
- Pain in the abdomen and lower back.
- Symptoms of overexertion and insufficient blood supply to organs.
Various laboratory and radiological studies are used to confirm the diagnosis. Laboratory tests may show changes in biomarkers indicating hemodynamic disturbances. Radiological examinations such as angiography, MRI, and CT allow visualization of changes in the vessels. Differential diagnosis includes exclusion of other diseases with similar symptoms, such as atherosclerosis and vasculitis.
Treatment
Treatment for FMD varies and depends on the severity of the disease. General measures may include:
- Lifestyle modification: weight control, physical activity, dietary changes.
- Pharmacological treatment: antihypertensive drugs to control blood pressure.
- Surgical treatment: angioplasty or reconstructive surgery on affected vessels in case of severe manifestations of the disease.
- Other treatments: Working with a psychologist to reduce stress and improve quality of life.
Each treatment method should be approached individually, depending on the patient’s condition and the characteristics of the disease.
List of medications used to treat this disease
The most common groups of drugs include:
- ACE inhibitors (losartan, enalapril).
- Beta blockers (metoprolol).
- Diuretics (hydrochlorothiazide).
A personalized approach based on a respectful assessment of the patient's condition is key in the pharmacotherapy of FMD.
Disease monitoring
Monitoring of patients with FMD includes regular blood pressure checks, assessment of kidney function, and imaging studies to monitor changes in the size and condition of blood vessels. Prognosis largely depends on the stage of the disease and the presence of complications. Potential complications may include stroke, myocardial infarction, the severity of which depends on the ability to control risk factors. Taking active steps to control the disease can significantly improve long-term outcomes.
Age-related features of the disease
FMD may present differently depending on the patient's age. In children, the disease is often asymptomatic and may only be discovered incidentally during other medical examinations. In young people and women, fibromuscular dysplasia often leads to arterial hypertension and vascular complications, which requires a preventive approach. In older patients, the disease may progress and develop pathologies associated with other vascular disorders.
Questions and Answers
- What are the main symptoms of fibromuscular dysplasia? The main symptoms include high blood pressure, abdominal and lower back pain, and possible signs of poor blood supply.
- How is FMD diagnosed? Diagnosis includes clinical examination, laboratory tests and radiological studies (CT, MRI).
- How is FMD treated? Treatment includes lifestyle changes, drug therapy, and possible surgical interventions.
- Who is at risk for FMD? The risk group includes women aged 15 to 50 years, as well as patients with connective tissue diseases.
- What is the prognosis for patients with FMD? The prognosis depends on the severity of the disease, control of risk factors and the presence of complications.
Advice from Dr. Oleg Korzhikov
Dr. Oleg Korzhikov recommends: “If you suspect fibromuscular dysplasia, it is important to immediately contact a specialist for a comprehensive assessment of the condition. Regular examinations and blood pressure monitoring play a critical role in preventing complications. Also, do not forget about lifestyle changes: a healthy diet and physical activity contribute to improving the condition and can minimize risks. Always discuss your symptoms with your doctor.”
